Aftovaxpur DOE


inactivated vaccine against foot-and-mouth disease

This medicine is now withdrawn from use in the European Union.


Aftovaxpur DOE has been withdrawn at the request of the marketing authorisation holder.

This EPAR was last updated on 04/07/2023

Authorisation details

Product details
Aftovaxpur DOE
Agency product number
Active substance
Maximum three of the following purified, inactivated foot-and-mouth disease virus strains: O1 Manisa ≥ 6 PD50*; O1 BFS ≥ 6 PD50*; O Taiwan 3/97 ≥ 6 PD50*; A22 Iraq ≥ 6 PD50*; A24 Cruzeiro ≥ 6 PD50*; A Turkey 14/98 ≥ 6 PD50*; Asia 1 Shamir ≥ 6 PD50*; SAT2 Saudi Arabia ≥ 6 PD50*; * PD50 – 50% protective dose in cattle as described in Ph. Eur. monograph 0063.
International non-proprietary name (INN) or common name
inactivated vaccine against foot-and-mouth disease
  • Pigs
  • Cattle
  • Sheep
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Boehringer Ingelheim Vetmedica GmbH
Date of issue of marketing authorisation valid throughout the European Union
Contact address

55216 Ingelheim am Rhein

Product information

20/03/2020 Aftovaxpur DOE - EMEA/V/C/002292 - IG/1204/G

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group


Therapeutic indication

Active immunisation of cattle, sheep and pigs from 2 weeks of age against foot-and-mouth disease to reduce clinical signs.

Assessment history

How useful was this page?

Add your rating
1 rating
2 ratings
1 rating